Stay updated on Resmetirom Safety and Biomarkers Clinical Trial
Sign up to get notified when there's something new on the Resmetirom Safety and Biomarkers Clinical Trial page.

Latest updates to the Resmetirom Safety and Biomarkers Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added and a generic funding/operational notice was removed; these are administrative updates to the website. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedA government funding status notice was added at the top of the page and the revision updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check48 days agoChange DetectedShow glossary was added to the page, and labels related to QC updates (Last Update Submitted that Met QC Criteria, No FEAR Act Data) were adjusted in capitalization; a new revision note 'Revision: v3.4.0' was added and older notes removed ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', 'Revision: v3.3.4'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision indicator updated: added v3.3.4 and removed v3.3.3 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedLocations are expanded to list all study sites by state with revision v3.3.3, and previously listed state locations plus the HHS Vulnerability Disclosure link have been removed.SummaryDifference2%

Stay in the know with updates to Resmetirom Safety and Biomarkers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Resmetirom Safety and Biomarkers Clinical Trial page.